Evidence map›Paper›PMID 30664693›Full record

ArticleNature materials2019

Sterile particle-induced inflammation is mediated by macrophages releasing IL-33 through a Bruton's tyrosine kinase-dependent pathway.

Pankaj K Mishra, Mark Palma, Bonnie Buechel, Jeffrey Moore, Viralkumar Davra, Niansheng Chu, Ariel Millman, Nadim J Hallab, Thirumala-Devi Kanneganti, Raymond B Birge and 5 more

Abstract read
In one paragraph

Article in Nature materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review.Current therapeutic research, clinical and experimental · 2022
    Review
  12. The Paradigm Change of IL-33 in Vascular Biology.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Reparative and Maladaptive Inflammation in Tendon Healing.Frontiers in bioengineering and biotechnology · 2021
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Pankaj K MishraDepartment of Medicine, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Mark PalmaDepartment of Medicine, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Bonnie BuechelDepartment of Orthopaedic Surgery, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Jeffrey MooreDepartment of Orthopaedic Surgery, Seton Hall University - St. Joseph's Regional Medical Center, Paterson, NJ, USA.
Viralkumar DavraDepartment of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Niansheng ChuDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ariel MillmanDepartment of Medicine, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Nadim J HallabDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA.
Thirumala-Devi KannegantiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Raymond B BirgeDepartment of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Edward M BehrensDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Amariliz RiveraCenter for Immunity and Inflammation, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Kathleen S BeebeCenter for Immunity and Inflammation, Rutgers - New Jersey Medical School, Newark, NJ, USA.
Joseph BeneveniaDepartment of Orthopaedic Surgery, Rutgers - New Jersey Medical School, Newark, NJ, USA.
William C GauseDepartment of Medicine, Rutgers - New Jersey Medical School, Newark, NJ, USA. gausewc@njms.rutgers.edu.ORCID http://orcid.org/0000-0002-8062-4790
Rutgers, The State University of New Jersey · USChildren's Hospital of Philadelphia · USRush University Medical Center · USSeton Hall University · USSt. Jude Children's Research Hospital · US

Funding

The Non-Inflammasome NLRs in Immunity and Host defenseR01AI124346 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2016 to 2026
$5.8M
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia SyndromesR01AI121250 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BEHRENS, EDWARD M, KAMBAYASHI, TAKU · 2016 to 2020
$3.0M
Protective and pathologic functions of macrophages induced by helminthsR01AI131634 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI GAUSE, WILLIAM CLARK, SIRACUSA, MARK CHRISTOPHER · 2018 to 2022
$2.6M
Inflammatory Caspases in Innate Immunity and InflammationR01AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2016
$2.2M
Purinergic signaling in granuloma-forming Th2 immunityR01DK113790 · NIDDK · RBHS-NEW JERSEY MEDICAL SCHOOL · PI GAUSE, WILLIAM CLARK, HASKO, GEORGE · 2017 to 2020
$1.9M
Regulation of antifungal immunity by monocyte-derived dendritic cellsR01AI114647 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI RIVERA, AMARILIZ · 2015 to 2019
$1.8M
Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced OsteolysisR01AR060782 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI HALLAB, NADIM JAMES · 2012 to 2016
$1.5M
NIAID NIH HHS R01 AI101935NIAID NIH HHS R01 AI114647NIAID NIH HHS R01 AI121250NIAID NIH HHS R01 AI124346NIAID NIH HHS R01 AI131634NIAMS NIH HHS R01 AR060782NIDDK NIH HHS R01 DK113790
6 · The paper itself

Abstract

Initiation of the innate sterile inflammatory response that can develop in response to microparticle exposure is little understood. Here, we report that a potent type 2 immune response associated with the accumulation of neutrophils, eosinophils and alternatively activated (M2) macrophages was observed in response to sterile microparticles similar in size to wear debris associated with prosthetic implants. Although elevations in interleukin-33 (IL-33) and type 2 cytokines occurred independently of caspase-1 inflammasome signalling, the response was dependent on Bruton's tyrosine kinase (BTK). IL-33 was produced by macrophages and BTK-dependent expression of IL-33 by macrophages was sufficient to initiate the type 2 response. Analysis of inflammation in patient periprosthetic tissue also revealed type 2 responses under aseptic conditions in patients undergoing revision surgery. These findings indicate that microparticle-induced sterile inflammation is initiated by macrophages activated to produce IL-33. They further suggest that both BTK and IL-33 may provide therapeutic targets for wear debris-induced periprosthetic inflammation.

Indexed as

Prosthesis FailureAgammaglobulinaemia Tyrosine KinaseArthroplastyCaspase 1HumansImmunity, InnateInflammationInterleukin-33MacrophagesSignal TransductionAgammaglobulinaemia Tyrosine KinaseCaspase 1Interleukin-33

Identifiers

PMID30664693
PMCPMC6581031
OpenAlexW2910973872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.